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Abstract 
 
Study Design: Systematic Review  
 
Objective: This review aims to (1) outline how neurological complications and disease 
progression are defined in the literature and (2) evaluate the quality of definitions using a 
novel four-point rating system.  
 
Summary of Background Data: Degenerative cervical myelopathy (DCM) is a progressive, 
degenerative spine disease that is often treated surgically. Although uncommon, surgical 
decompression can be associated with neurological complications, such as C5 nerve root 
palsy, perioperative worsening of myelopathy and longer-term deterioration. Unfortunately, 
important questions surrounding these complications cannot be fully addressed due to the 
heterogeneity in definitions used across studies. Given this variability, there is a pressing 
need to develop guidelines in the reporting of surgical complications in order to accurately 
evaluate the safety of surgical procedures.  
 
Methods: An electronic database search was conducted in MEDLINE, MEDLINE in 
Process, EMBASE and Cochrane Central Register of Controlled Trials for studies that 
reported on complications related to DCM surgery and included at least 10 surgically treated 
patients. Data extracted included study design, surgical details, and definitions and rates of 
surgical complications. A four-point rating scale was developed to assess definition quality 
for each complication.  
 
Results: Our search yielded 2,673 unique citations, 42 of which met eligibility criteria and 
were summarized in this review. Defined complications included neurological deterioration, 
late onset deterioration, perioperative worsening of myelopathy, C5 palsy, nerve root or upper 
limb palsy or radiculopathy, surgery failure, inadequate decompression and progression of 
ossified lesions. Reported rates of these complications varied substantially, especially those 
for neurological deterioration (0.2% to 33.3%) and progression of ossified lesions (0.0% to 
86.7%).  
 
Conclusions: Reported incidences of various complications vary widely in DCM surgery, 
especially for neurological deterioration and progression of ossified lesions. This summary 
serves as a first step for standardizing definitions and developing guidelines for accurately 
reporting surgical complications.   
 
Key Words: degenerative cervical myelopathy; ossification of the posterior longitudinal 
ligament; cervical spondylotic myelopathy; complications; C5 palsy; radiculopathy; spinal 
cord injury; manual muscle test; neurological deterioration; inadequate decompression; 
surgery failure; progression of ossified lesions 
 
Level of Evidence: 2 
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Key Points 
 
1. Surgical decompression for degenerative cervical myelopathy (DCM) can arrest 
disease progression and improve functional impairment, disability and quality of life.  
2. Surgery, however, is associated with complications, including intraoperative spinal 
cord injury, deterioration of myelopathy, C5 nerve root palsy, new radiculopathy and 
decreased strength.  
3. Reported rates of neurological complications vary considerably across published 
studies; this is likely due to the heterogeneity of definitions used to characterize these 
complications. 
4. This review outlines how neurological complications and disease progression are 
defined in the literature and serves as an initial step in unifying terminology.  
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Introduction 
 
Degenerative cervical myelopathy (DCM) results from the degeneration of various 
components of the spinal axis and is the most common cause of spinal cord dysfunction in 
adults worldwide.1 The term DCM comprises cervical spondylotic myelopathy (CSM); 
ossification, calcification or hypertrophy of the spinal ligaments; degenerative disc disease 
(DDD); and other compressive degenerative pathologies.2,3 The natural history of DCM is 
variable: some patients are clinically stable or may even improve over time, while others 
experience rapid neurological progression.1,4 Patients with stable and mild myelopathy can be 
managed non-operatively with close observation, while those with progressive and/or 
moderate to severe disease typically require surgical intervention.5 Surgical decompression 
can be performed anteriorly and/or posteriorly, depending on factors such as cause and extent 
of compression, cervical alignment, presence of axial neck pain, age, and stability of the 
spinal column.  
Several prospective studies have demonstrated that surgical decompression of the spinal cord 
can arrest disease progression and improve functional impairment, disability and quality of 
life.6,7 Surgery, however, carries a risk of adverse events, including neurological 
complications such as intraoperative spinal cord injury, deterioration of myelopathy and C5 
palsy. Furthermore, patients with ossification of the posterior longitudinal ligament (OPLL) 
may experience progression of their lesion following surgery.  
Reported rates of neurological complications and disease progression vary considerably 
across published studies. This variation can be partly attributed to differences in surgical 
expertise but is more likely due to the heterogeneity of definitions used to characterize these 
complications. For example, in a study by Machino et al, C5 palsy was defined as “paresis of 
deltoid (manual muscle test (MMT) score of 1 or 2), with or without involvement of the 
biceps, but no loss of strength in other muscles.” The reported incidence of C5 palsy in this 
Copyright © 2019 Wolters Kluwer Health, Inc. Unauthorized reproduction of this article is prohibited.
study was 0.6%.8 In contrast, Liu et al indicated a much higher incidence (23.1%) using 
different criteria: “1 grade deterioration on MMT of the deltoid postoperatively, apparent 
sensory deficits or only pain at the C5 dermatome area.”9 Furthermore, study design and 
method of data collection may also significantly influence reported rates of complications.  
This lack of standardization prevents (1) an accurate assessment of surgical safety, (2) an 
evaluation of relevant risk factors of neurological complications and (3) an analysis of the 
impact of adverse events on patient satisfaction, cost, disability and functional impairment. 
Due to this inconsistency, there is a pressing need to develop high-quality standardized 
definitions of surgical complications. This review outlines how neurological complications 
and disease progression are defined in the literature and evaluates the quality of these 




Studies were considered for inclusion if they had 10 or more adult patients (≥18 years of age) 
with DCM (cord compression caused by spondylosis, disc herniation, OPLL, hypertrophy of 
the ligamentum flavum (HLF), dynamic factors and/or progressive kyphosis) treated 
surgically and evaluated postoperatively. Studies also must have defined one or more 
complications related to surgical intervention. 
Studies were excluded if they included patients with isolated radiculopathy or non-
degenerative causes of myelopathy such as trauma, tumour and rheumatoid arthritis. Case 
reports, meta-analyses, systematic reviews, editorials, commentaries, and conference 
proceedings were also excluded.   
Information Sources 
An electronic database search was conducted in MEDLINE, MEDLINE in Process, 
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EMBASE, and Cochrane Central Register of Controlled Trials for literature published up 
until January 22nd, 2016. 
Search 
The search strategy was first developed in MEDLINE and then modified for the other three 
databases. The following general terms were used to search all databases: (DCM OR CSM 
OR OPLL) AND surgery AND (adverse events OR complications). Other keywords were 
also used, including those related to specific neurological complications such as “paralysis”, 
“pals*,” “radiculopath*,” “worse* adj4 myelopath*,” “progress* adj4 myelopath*” and 
others.  Only studies on humans and written in English were considered. Four libraries were 
used to access the full texts of articles. Articles referenced by relevant studies were also 
included. 
Study Selection 
All duplicates, conference abstracts, systematic or literature reviews, commentaries, letters, 
case reports and studies in other languages were excluded. The remaining abstracts and titles 
were reviewed and sorted by three independent investigators (L.T., S.C., M.T.K.) as possibly 
relevant or irrelevant. The full texts of the articles classified as possibly relevant were 
examined by a fourth reviewer (S.F.L.). Uncertainty about inclusion was resolved through 
discussion and consensus. Final decisions were reviewed and approved by the senior author 
(M.G.F). 
Data extraction and synthesis 
The following data were extracted from each article where available: title, author, year, study 
design, number of patients, diagnosis, type of surgery, follow-up period/average length of 
follow-up, and the type, definition, incidence, onset and duration of complications.  
When extracting data, two definitions were considered the same if they did not have 
clinically relevant differences. For example, the following definitions for C5 palsy would be 
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considered similar: “paralysis of the deltoid and/or biceps muscle(s)” and “weakness in the 
muscles corresponding to the C5 myotome”; both imply that there is a loss in strength of the 
muscles corresponding to the C5 nerve root. In contrast, the definition “upper extremity 
weakness” would be considered different. 
Rating of Individual Definitions  
A novel four-point rating system was created to evaluate the quality of a complication 
definition: “COMP,” Clinical finding, Objective criteria, Modality and Point in time. A single 
point was granted for each of the following criterion:  
A. The complication is linked to a clinical finding and is described qualitatively; 
B. The modality of identifying the complication is described (X-ray, magnetic resonance 
imaging (MRI), computed tomography (CT), lab, patient-reported, etc.); 
C. The clinical finding is described quantitatively by a measurement or has been 
categorized based on objective criteria. If the complication was described 
quantitatively, a point for Criterion (A) was automatically awarded; 
D. The time of evaluation after surgery was defined (days, weeks, months etc.) 
This rating scale was developed and modified by consensus among the authors. Each 
criterion was selected based on trends in current definitions. To score higher, a definition 
must have a quantitative description; the rationale behind this requirement is that quantitative 
assessments leave less room for interpretation and should result in a more consistent 
reporting of the complication. Iterative versions of this system were evaluated for inter-rater 
reliability. The four-point scale described above demonstrated the highest reliability (93.6%). 
Table 1 uses C5 palsy as an example to illustrate how definitions are rated using this system. 
Reporting 
This systematic review was formatted, where applicable, using the Preferred Reporting Items 
for Systematic Reviews and Meta-Analyses (PRISMA) statement.10 For the purpose of this 
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review, it was not necessary to evaluate the risk of bias of each individual article or assess the 
strength of the overall body of evidence. Instead, we rated the quality of each definition using 




Our literature search yielded 2,673 unique citations. We excluded 1,546 articles following 
abstract and title review. A total of 1,128 studies underwent full text review, 1,086 of which 
were excluded. Common reasons for exclusion were that the study (1) included patients with 
only radiculopathy or with myelopathy secondary to trauma, tumour or rheumatoid arthritis, 
(2) did not discuss neurological complications or disease progression, and (3) did not define 
reported complications. A total of 42 studies satisfied our inclusion criteria.   
Study Characteristics  
The 42 articles that discussed neurological complications or progression of ossification were 
published between 1991 and 2016. Fifteen studies (35.7%) were prospective and 27 (64.3%) 
were retrospective (Table 2). Sample sizes ranged from 13 to 1,858 patients.  
Complication definitions 
The reviewed studies included definitions for the following complications: neurologic 
deterioration (n=5)11-15, late onset deterioration (n=6)15-20, perioperative worsening of 
myelopathy (n=1)13, progression of ossified lesions (n=10)16-25, C5 palsy (n=20)8,9,13,26-42, 
nerve root/upper limb palsy or new radiculopathy (n=6)13,43-47, decreased arm strength 
(n=1)44, surgery failure (n=1)48 and inadequate decompression (n=2)26,49,50. Table 2 
summarizes the included articles and lists complication definitions, study design, timing of 
follow-up, surgical approach, and incidence. Table 3 displays the reported incidences of 
surgical complications. 
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Neurological deterioration 
Ten studies defined neurological deterioration and/or late-onset deterioration.11-20 
Of the five definitions provided for neurological deterioration, one scored one point and four 
scored three points on our rating scale. Four studies used quantitative definitions: (1) a 
decrease in Japanese Orthopaedic Association (JOA) score or an increase in Nurick Grade by 
1 point11; (2) a decrease of ≥3 points in the JOA score12; (3) a decrease of >2 points on the 
JOA score after initial postoperative recovery;15 and (4) an increase of ≥1 Nurick grade14. 
Tetreault et al. qualitatively defined deterioration as an “increase of myelopathic signs and 
symptoms13.” Reported incidences ranged from 0.2% to 30.8%.  
Late-onset deterioration was defined by six studies. Based on our rating scale, three 
definitions received three points and three scored four points. All definitions were based on a 
decrease in the total JOA score or subscores of this scale. Quantitative criteria included (1) a 
decrease by >117, >218 or >316 points on the total JOA; and (2) a decrease in upper extremity 
and trunk JOA scores by >119 or >220 points. In two studies, the reference value used to 
evaluate deterioration was the maximum score of the patient during a 4-year16 or a 1 to 5 
year19 follow-up. A third study by Goto et al classified late deterioration as a decline 
following 10 years of postoperative recovery. Reported incidences ranged from 4.5% to 
33.3%. 
Perioperative Worsening of Myelopathy 
Tetreault et al defined perioperative worsening of myelopathy as “signs and symptoms due to 
cervical myelopathy worsening during the initial four-week postoperative period” (rating = 
2).13 The reported incidence was 0.6% in this prospective cohort of 477 patients. 
Progression of Ossified Lesions 
Ten studies defined progression of ossified lesions16-25. Of these definitions, three scored two 
points, five scored three points, and one scored four points on our rating scale. The majority 
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of studies defined progression of ossification as an increase in the longitudinal or axial extent 
or sagittal thickness of the lesion. Quantitative definitions for progression included (1) >50% 
of one vertebral body axially16,25, (2) longitudinal growth over one vertebral body22, (3) 
>216,22,25 or ≥223,24 mm in thickness, (4) >1 mm in thickness21 or (5) >221 or ≥223,24 mm in 
longitudinal extent. Two studies by Ogawa et al. defined this complication as a progression of 
the ossified ligament by >2 mm, but did not specify the direction of the progression19,20. 
Finally, the definition by Iwasaki et al. was all-encompassing and included a ≥2 mm increase 
in the existing lesion, the appearance of a new ossified lesion measuring ≥2 mm and bridging 
between separate lesions to form a continuous lesion18.  
Chiba et al used computer-assisted measurements to quantify progression of OPLL17. This 
method was originally developed by Chiba and colleagues in 2005 and demonstrated 98% 
precision to differentiate a 2 mm difference in length or thickness of OPLL51. 
The imaging modality used to assess progression of ossification was lateral radiographs in six 
studies16,19-21,23-25 and lateral tomograms in a single study24.  
The studies by Chen et al. reported low incidences of progression between 0.0%25 and 
6.7%16. In the remaining studies, incidences ranged from 42.4% to 86.7%.   
C5 Palsy 
Twenty studies contained 15 definitions for C5 palsy: four scored one point, one scored two 
points, and eleven scored three points on our rating scale. Twelve definitions used the manual 
muscle test (MMT) to evaluate muscle weakness or reduction in motor strength. Quantitative 
definitions of C5 palsy included (1) a deterioration in muscle power or strength by ≥1 grade 
on the MMT;9,29,32,36,40-42 and (2) muscle weakness represented by a MMT grade of 126, 1 or 
28,33,34, <328,37 or ≤338,39. Reported incidences in studies that used criterion (1) ranged from 
3.3% to 23.1% and, in those that used criterion (2), from 0.6% to 6.4%. A single study by 
Sasai et al. used the MMT to diagnose C5 palsy but did not specify quantitative criteria 
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(incidence = 2.7%)31. Some definitions specified that this decrease in strength or weakness 
had to be limited to the deltoid9,37-39; the deltoid with or without involvement of the biceps 
brachii8,32-34; the deltoid and biceps brachii26,40,41; the deltoid or biceps brachii36; or the upper 
limb29. Furthermore, several definitions indicated that this weakness or reduction in strength 
could not be accompanied by deterioration of neurologic40,41 or myelopathic symptoms38,39, 
aggravation of lower extremity function36 or loss of strength of other muscles8,32-34. A single 
study by Liu et al also included in their definition of C5 palsy an “apparent sensory deficit or 
pain in the C5 dermatome area”9; the reported incidence of this complication was 23.1%. 
Four studies provided more qualitative definitions of C5 palsy, including (1) postoperative 
symptoms of paresis of the deltoid or biceps brachii muscles35; (2) deterioration of muscle or 
motor strength in the deltoid and/or biceps brachii muscles27,30; (3) sensory deficits or 
increased pain in the C5 nerve root distribution27,35; (4) C5 dermatome hypoesthesia13; and 
(5) diminished or absent bicipital reflex13. Incidences of C5 palsy reported by these studies 
ranged from 0.8%13 to 12.2%35.  
 
Nerve Root Palsy/Upper Limb Palsy and New Radiculopathy 
Six studies featured definitions of nerve root palsy, upper limb palsy, and new radiculopathy. 
Of these studies, one scored one point, four scored three points, and one scored four points on 
our rating scale. Four definitions described upper limb palsy or radiculopathy as a loss of 
motor function defined (1) by a reduction in MMT by ≥1 grade in upper limb muscle 
strength44,45 (incidences ranged from 5.0 to 6.2%); (2) by weakness of grade 4 or less in key 
muscles of the upper extremity43 (incidence was 15.7%); or (3) using a scale from mild to 
severe motor paralysis using MMT criteria46,47 (mild = 4 to 5; moderate = 2 to 3; severe = 0 
to 1; incidences ranged from 10.6% to 12.9%). Three of these studies indicated that this 
reduction in strength could not be accompanied by deterioration in myelopathy symptoms44 
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or aggravation of lower extremity function45. Three studies differentiated between sensory- 
and motor-dominant palsy. In a study by Dai et al, sensory-dominated palsy was defined as 
“sensory loss and/or retractable pain with little motor impairment.”47 In a second study by 
Tsuzuki et al, patients were diagnosed with sensory-dominant palsy if “muscle power 
improved after pain was relieved by a root block even if the muscle weakness was associated 
with radicular pain.”46 Finally, in a third study by Hasegawa et al, the appearance of a new 
sensory disturbance between day 0 and 2 months after surgery was sufficient for a diagnosis 
of sensory nerve root palsy45. 
The study by Hasegawa et al also specified how the level of neurologic dysfunction was 
determined: weakness of the deltoid and biceps brachii and/or abnormal reflex of the biceps 
tendon for C5; weakness of the biceps brachii and wrist extensors and/or abnormal reflex of 
the brachioradialis tendon for C6; weakness of the triceps and/or abnormal reflex of the 
triceps tendon for C7; and weakness of the wrist flexors and decrease in grip strength for 
C845. Furthermore, levels of sensory disturbance were determined using the criteria proposed 
by Keegan and Garrett.  
Finally, a single study by Tetreault et al defined new radiculopathy as “signs and symptoms 
of other cervical spinal root lesions13” (rating = 1). The incidence of this complication was 
0.6%.  
Decreased Arm Strength  
In a study by Takenaka et al, a calibrated hand-held dynamometer was used to assess 
shoulder abduction, elbow flexion and elbow extension, indicating the strength of the deltoid, 
biceps brachii and triceps brachii respectively44. Additionally, grip strength was evaluated 
using a grip dynamometer. Decreased arm strength was defined as decreased strength of at 
least one muscle as determined by one or both of these assessments (rating = 4). The reported 
incidence in this study was 11.3%.  
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Surgery Failure 
A single study defined surgery failure (rating = 3).48 In the study by Saunders et al, 
improvement was defined as a change of at least two grades in the Nurick classification, 
and/or resolution of hyperpathia and dysesthesia. A smaller grade of improvement, or 
regression was considered a failure. The reported incidence of failure was 12.8%.  
Inadequate decompression 
Three studies defined inadequate decompression.26,49,50 Two studies by Chen et al considered 
surgical decompression to be inadequate when the cord flattening ratio (minor axis length of 
the spinal cord divided by major axis length at the level of maximal cord compression on 
axial T1-weighted MRI) was less than 0.4 following operation (rating=3). 26,50 
Hirai et al (2011) reported rates of residual anterior compression, defined as (1) effacement of 
anterior cerebrospinal fluid buffer on T2-sagittal and axial images, or (2) evidence of anterior 
compression of cord substance on T1-sagittal and axial images (rating=2)49. Their 
radiographic analysis was performed by three independent, blinded spine surgeons. The 
reported incidence of residual compression increased over time, from 12.8% post-operatively 
to 37.5% at two years following surgery.  
 
Discussion 
An accurate evaluation of complications following surgery for DCM is essential for 
determining quality of care, comparing outcomes among various surgical approaches, and 
developing enhanced treatment protocols. Currently, there are no standardized criteria for 
defining or reporting complications; this knowledge gap prevents an accurate assessment of 
the safety of surgery, the identification of relevant risk factors and the implementation of 
appropriate prevention strategies. This systematic review aimed to summarize current 
definitions of neurological complications and disease progression as a first step in developing 
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a unified classification system. Based on our results, reported rates of these complications 
varied substantially, especially for neurological deterioration and progression of ossified 
lesions. These wide ranges can likely be attributed to the heterogeneity of definitions used 
across studies as well as the variability in methods of data collection, study design and timing 
of evaluation.  
Several studies reported rates of neurological deterioration by evaluating changes in 
either the JOA or Nurick score. Unfortunately, there was no consistency across studies with 
respect to the extent of decline required for a diagnosis of deterioration. There are certain 
drawbacks to using a scale like the JOA to evaluate progression of myelopathy. First, 
although the JOA exhibits high reliability (ICC=0.826)52, it is possible that a decrease in the 
JOA by a single point reflects inter- or intra-observer variability. Furthermore, based on the 
study by Yonenobu et al, inter- and intra-observer agreement is particularly low for certain 
JOA subscales, namely the lower extremity motor score (62.3% and 62.2%, respectively) and 
the lower extremity sensory score (62.3% and 57.1%, respectively)52. As a result, a diagnosis 
of neurological deterioration should be based on a decrease of at least two points on the JOA 
score, which has been accepted as the minimum clinically important (MCID) difference for 
this scale. Consequently, the study by Chiba et al may have overestimated rates of late 
neurological deterioration in patients treated surgically for DCM.17 A second issue is that a 
decline in a patient’s JOA may not necessarily represent progression of myelopathy, but may 
indicate either concomitant lumbar spinal stenosis or the presence of other co-morbidities that 
limit a patient’s ability to perform certain tasks on the JOA. Finally, the timing of assessment 
is critical. The onset of new radicular or myelopathic symptoms may occur years after 
surgical decompression due to progressive kyphosis, progression of ossified lesions or the 
development of spondylotic changes at levels adjacent to the treated segments. In contrast, 
“early” neurologic deterioration or worsening of myelopathy are likely not a result of 
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adjacent segment degeneration but could be due to surgeon error, inadequate decompression, 
dynamic cord compression or ischemia reperfusion injury; as such, the etiology of neurologic 
deterioration should be described. Specific timing thresholds must be defined to effectively 
differentiate between early and late onset of deterioration.  
It is controversial whether progression of an ossified lesion should be considered a 
complication or a consequence of the natural history of the disease. In this review, reported 
rates varied widely depending on whether the definition included “progression of more than 
half of one vertebral body” (0.0% to 6.7%) or just specified an increase in the longitudinal or 
axial extent of the lesion (42.4% to 86.7%). It is unclear why these incidences differed so 
drastically, especially since the two studies by Chen et al. also included “progression of more 
than 2 mm in thickness” as part of their criteria. A possible explanation for these lower rates 
is that patients were treated with a hybrid posterior procedure that included both a 
laminoplasty and a lateral mass screw fixation at the unstable levels – this fixation may 
decrease dynamic causes of myelopathy, stabilize the environment around the spinal cord and 
ultimately prevent further progression16,25. In addition, as duration of follow-up increases, the 
incidence of this complication would likely also increase. Other issues in determining rates of 
progression include measurement error, variable quality of radiographs and differences 
between pre- and post-operative images, including in magnification and contrast 
characteristics. Chiba et al. developed a rigorous methodology to address some of these 
issues and accurately evaluate both the length and thickness of ossified lesions51. This system 
used lateral radiographs and a computer-assisted measurement system and was able detect a 
2-mm change in length or thickness with 98% of precision.   
 The onset of radiculopathy (typically at the C5 level) following surgical 
decompression has been extensively studied. Current hypotheses for this complication 
include a traumatic surgical procedure, edema of the spinal cord or tethering of the nerve 
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root.53 Another explanation was recently proposed by Karadimas et al using a novel CSM rat 
model54. Based on their results, C5 palsy and other neurological complications may be 
associated with ischemia reperfusion injury that occurs following surgical decompression. 
Unfortunately, it is still unclear what the exact incidence of this complication is, whether it is 
associated with a specific surgical procedure or if there are certain baseline or imaging 
characteristics that increase a patient’s risk. This uncertainty was confirmed in a systematic 
review of the literature which indicated there was insufficient evidence to determine the 
association between C5 palsy or upper extremity paresis and cervical alignment, number of 
compressed segments, position of the superior articular process, cord inclination, high signal 
intensity on T2-weighted MRI, occupying ratio, number of operated laminae, operative 
duration, and estimated blood loss53. The inability to answer these questions stems from the 
lack of consistency in definitions across studies. Although almost all definitions of C5 palsy 
specified a reduction in strength of the deltoid and/or biceps brachii muscles, there was 
substantial variation in MMT and exclusion criteria. Similar heterogeneity was identified in 
studies evaluating upper extremity palsy or new radiculopathy. The MCID for the MMT and 
other relevant scales should be used to identify cases of new radiculopathy.  
 Finally, none of the definitions for inadequate decompression considered the clinical 
status of the patient. Instead, all definitions were solely based on MRI findings, including 
cord flattening ratio, effacement of the anterior cerebrospinal fluid buffer and evidence of 
anterior cord compression. Given discrepancies between imaging findings and patient 
presentation, it is also important to consider improvement or regression of myelopathic 
symptoms when defining inadequate decompression.  
 This review represents the first part of a larger effort to develop guidelines for 
reporting surgical complications in the setting of DCM. This process will incorporate results 
from the current body of literature as well as clinical expertise. Before the development of 
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this classification system, we suggest that future research on surgical safety report the 
following factors: definition of the complication studied, method of data collection (e.g. 
nurse, surgeon, research coordinator, self-reports), duration of follow-up, rates of mortality 
and causes, grading system used to evaluate severity, readmission or reoperation and 
percentage lost at follow-up. This knowledge will allow for more accurate reporting of 
complications, facilitate improved interpretation of results on surgical safety, and enable 
integration of larger national and international databases through common data elements.  
 
Conclusion 
Reported incidences of neurologic complications and disease progression vary widely in 
DCM surgery. There is a pressing need to standardize definitions and develop guidelines for 
accurately reporting surgical complications. In the interim, we suggest that authors define 
complications in accordance with our four-point rating scale and report methods of data 
collection, study design and management strategies.  
Copyright © 2019 Wolters Kluwer Health, Inc. Unauthorized reproduction of this article is prohibited.
References 
1. Tetreault L, Goldstein CL, Arnold P, et al. Degenerative Cervical Myelopathy: A Spectrum of 
Related Disorders Affecting the Aging Spine. Neurosurgery. 2015;77 Suppl 4:S51-67. 
2. Nouri A, Tetreault L, Singh A, Karadimas SK, Fehlings MG. Degenerative Cervical 
Myelopathy: Epidemiology, Genetics, and Pathogenesis. Spine (Phila Pa 1976). 
2015;40(12):E675-693. 
3. Kalsi-Ryan S, Karadimas SK, Fehlings MG. Cervical spondylotic myelopathy: The clinical 
phenomenon and the current pathobiology of an increasingly prevalent and devastating 
disorder. Neuroscientist. 2013;19(4):409-421. 
4. Karadimas SK, Erwin WM, Ely CG, Dettori JR, Fehlings MG. Pathophysiology and natural 
history of cervical spondylotic myelopathy. Spine (Phila Pa 1976). 2013;38(22 Suppl 1):S21-
36. 
5. Fehlings MG, Tetreault LA, Riew KD, et al. A Clinical Practice Guideline for the 
Management of Patients With Degenerative Cervical Myelopathy: Recommendations for 
Patients With Mild, Moderate, and Severe Disease and Nonmyelopathic Patients With 
Evidence of Cord Compression. Global Spine J. 2017;7(3 Suppl):70S-83S. 
6. Fehlings MG, Wilson JR, Kopjar B, et al. Efficacy and safety of surgical decompression in 
patients with cervical spondylotic myelopathy: results of the AOSpine North America 
prospective multi-center study. J Bone Joint Surg Am. 2013;95(18):1651-1658. 
7. Fehlings MG, Ibrahim A, Tetreault L, et al. A global perspective on the outcomes of surgical 
decompression in patients with cervical spondylotic myelopathy: results from the prospective 
multicenter AOSpine international study on 479 patients. Spine (Phila Pa 1976). 
2015;40(17):1322-1328. 
8. Machino M, Yukawa Y, Hida T, et al. Modified double-door laminoplasty in managing 
multilevel cervical spondylotic myelopathy: Surgical outcome in 520 patients and technique 
description. Journal of Spinal Disorders and Techniques. 2013;26(3):135-140. 
9. Liu T, Zou W, Han Y, Wang Y. Correlative study of nerve root palsy and cervical posterior 
decompression laminectomy and internal fixation. Orthopedics. 2010;33(8). 
10. Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic 
reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and 
elaboration. Bmj. 2009;339:b2700. 
11. Asgari S, Bassiouni H, Massoud N, Schlamann M, Stolke D, Sandalcioglu IE. Decompressive 
laminoplasty in multisegmental cervical spondylotic myelopathy: bilateral cutting versus 
open-door technique. Acta Neurochir (Wien). 2009;151(7):739-749. 
12. Kato Y, Iwasaki M, Fuji T, Yonenobu K, Ochi T. Long-term follow-up results of 
laminectomy for cervical myelopathy caused by ossification of the posterior longitudinal 
ligament. J Neurosurg. 1998;89(2):217-223. 
Copyright © 2019 Wolters Kluwer Health, Inc. Unauthorized reproduction of this article is prohibited.
13. Tetreault L, Tan G, Kopjar B, et al. Clinical and Surgical Predictors of Complications 
Following Surgery for the Treatment of Cervical Spondylotic Myelopathy: Results From the 
Multicenter, Prospective AOSpine International Study of 479 Patients. Neurosurgery. 
2016;79(1):33-44. 
14. Fessler RG, Steck JC, Giovanini MA. Anterior cervical corpectomy for cervical spondylotic 
myelopathy. Neurosurgery. 1998;43(2):257-267. 
15. Goto S, Mochizuki M, Watanabe T, et al. Long-term follow-up study of anterior surgery for 
cervical spondylotic myelopathy with special reference to the magnetic resonance imaging 
findings in 52 cases. Clinical Orthopaedics and Related Research. 1993(291):142-153. 
16. Chen Y, Chen D, Wang X, et al. Significance of segmental instability in cervical ossification 
of the posterior longitudinal ligament and treated by a posterior hybrid technique. Arch 
Orthop Trauma Surg. 2013;133(2):171-177. 
17. Chiba K, Ogawa Y, Ishii K, et al. Long-term results of expansive open-door laminoplasty for 
cervical myelopathy - Average 14-year follow-up study. Spine. 2006;31(26):2998-3005. 
18. Iwasaki M, Okuda S, Miyauchi A, et al. Surgical strategy for cervical myelopathy due to 
ossification of the posterior longitudinal ligament: Part 1: Clinical results and limitations of 
laminoplasty. Spine. 2007;32(6):647-653. 
19. Ogawa Y, Chiba K, Matsumoto M, et al. Long-term results after expansive open-door 
laminoplasty for the segmental-type of ossification of the posterior longitudinal ligament of 
the cervical spine: a comparison with nonsegmental-type lesions. J Neurosurg Spine. 
2005;3(3):198-204. 
20. Ogawa Y, Toyama Y, Chiba K, et al. Long-term results of expansive open-door laminoplasty 
for ossification of the posterior longitudinal ligament of the cervical spine. J Neurosurg Spine. 
2004;1(2):168-174. 
21. Onari K, Akiyama N, Kondo S, Toguchi A, Mihara H, Tsuchiya T. Long-term follow-up 
results of anterior interbody fusion applied for cervical myelopathy due to ossification of the 
posterior longitudinal ligament. Spine. 2001;26(5):488-493. 
22. Satomi K, Nishu Y, Kohno T, Hirabayashi K. Long-term follow-up studies of open-door 
expansive laminoplasty for cervical stenotic myelopathy. Spine. 1994;19(5):507-510. 
23. Sakaura H, Hosono N, Mukai Y, Iwasaki M, Yoshikawa H. Medium-term outcomes of C3-6 
laminoplasty for cervical myelopathy: A prospective study with a minimum 5-year follow-up. 
Eur Spine J. 2011;20(6):928-933. 
24. Kawaguchi Y, Kanamori M, Ishihara H, et al. Progression of ossification of the posterior 
longitudinal ligament following en bloc cervical laminoplasty. Journal of Bone and Joint 
Surgery - Series A. 2001;83(12):1798-1802+adv1730. 
Copyright © 2019 Wolters Kluwer Health, Inc. Unauthorized reproduction of this article is prohibited.
25. Chen Y, Wang X, Chen D, Miao J, Liao X, Yu F. Posterior hybrid technique for ossification 
of the posterior longitudinal ligament associated with segmental instability in the cervical 
spine. J Spinal Disord Tech. 2014;27(4):240-244. 
26. Chen Y, Guo Y, Chen D, et al. Diagnosis and surgery of ossification of posterior longitudinal 
ligament associated with dural ossification in the cervical spine. Eur Spine J. 
2009;18(10):1541-1547. 
27. Yuan W, Zhu Y, Liu X, et al. Postoperative three-dimensional cervical range of motion and 
neurological outcomes in patients with cervical ossification of the posterior longitudinal 
ligament: Cervical laminoplasty versus laminectomy with fusion. Clinical Neurology and 
Neurosurgery. 2015;134:17-23. 
28. Yeh KT, Yu TC, Chen IH, et al. Expansive open-door laminoplasty secured with titanium 
miniplates is a good surgical method for multiple-level cervical stenosis. J. 2014;9:49. 
29. Yanase M, Matsuyama Y, Mori K, et al. Intraoperative spinal cord monitoring of C5 palsy 
after cervical laminoplasty. Journal of Spinal Disorders and Techniques. 2010;23(3):170-175. 
30. Shiozaki T, Otsuka H, Nakata Y, et al. Spinal cord shift on magnetic resonance imaging at 24 
hours after cervical laminoplasty. Spine. 2009;34(3):274-279. 
31. Sasai K, Saito T, Akagi S, Kato I, Ohnari H, Iida H. Preventing C5 palsy after laminoplasty. 
Spine. 2003;28(17):1972-1977. 
32. Nakashima H, Imagama S, Yukawa Y, et al. Multivariate analysis of C-5 palsy incidence 
after cervical posterior fusion with instrumentation: Clinical article. Journal of Neurosurgery: 
Spine. 2012;17(2):103-110. 
33. Imagama S, Matsuyama Y, Yukawa Y, et al. C5 palsy after cervical laminoplasty: a 
multicentre study. J Bone Joint Surg Br. 2010;92(3):393-400. 
34. MacHino M, Yukawa Y, Ito K, et al. Impact of diabetes on the outcomes of cervical 
laminoplasty: A prospective cohort study of more than 500 patients with cervical spondylotic 
myelopathy. Spine. 2014;39(3):220-227. 
35. Lubelski D, Derakhshan A, Nowacki AS, et al. Predicting C5 palsy via the use of 
preoperative anatomic measurements. Spine Journal. 2014;14(9):1895-1901. 
36. Kim S, Lee SH, Kim ES, Eoh W. Clinical and radiographic analysis of C5 palsy after anterior 
cervical decompression and fusion for cervical degenerative disease. Journal of Spinal 
Disorders and Techniques. 2014;27(8):436-441. 
37. Katsumi K, Yamazaki A, Watanabe K, Ohashi M, Shoji H. Analysis of C5 palsy after 
cervical open-door laminoplasty: Relationship between C5 palsy and foraminal stenosis. 
Journal of Spinal Disorders and Techniques. 2013;26(4):177-182. 
38. Katsumi K, Yamazaki A, Watanabe K, Ohashi M, Shoji H. Can prophylactic bilateral C4/C5 
foraminotomy prevent postoperative C5 palsy after open-door laminoplasty?: A prospective 
study. Spine. 2012;37(9):748-754. 
Copyright © 2019 Wolters Kluwer Health, Inc. Unauthorized reproduction of this article is prohibited.
39. Ohashi M, Yamazaki A, Watanabe K, Katsumi K, Shoji H. Two-year clinical and radiological 
outcomes of open-door cervical laminoplasty with prophylactic bilateral C4-C5 
foraminotomy in a prospective study. Spine. 2014;39(9):721-727. 
40. Odate S, Shikata J, Yamamura S, Soeda T. Extremely wide and asymmetric anterior 
decompression causes postoperative C5 palsy: An analysis of 32 patients with postoperative 
C5 palsy after anterior cervical decompression and fusion. Spine. 2013;38(25):2184-2189. 
41. Kaneyama S, Sumi M, Kanatani T, et al. Prospective study and multivariate analysis of the 
incidence of C5 palsy after cervical laminoplasty. Spine. 2010;35(26):E1553-E1558. 
42. Ikenaga M, Shikata J, Tanaka C. Radiculopathy of C-5 after anterior decompression for 
cervical myelopathy. J Neurosurg Spine. 2005;3(3):210-217. 
43. Wu FL, Sun Y, Pan SF, Zhang L, Liu ZJ. Risk factors associated with upper extremity palsy 
after expansive open-door laminoplasty for cervical myelopathy. Spine Journal. 
2014;14(6):909-915. 
44. Takenaka S, Hosono N, Mukai Y, Miwa T, Fuji T. The use of cooled saline during bone 
drilling to reduce the incidence of upper-limb palsy after cervical laminoplasty. Journal of 
Neurosurgery: Spine. 2013;19(4):420-427. 
45. Hasegawa K, Homma T, Chiba Y. Upper extremity palsy following cervical decompression 
surgery results from a transient spinal cord lesion. Spine. 2007;32(6):E197-E202. 
46. Tsuzuki N, Abe R, Saiki K, Okai K. Paralysis of the arm after posterior decompression of the 
cervical spinal cord. II. Analyses of clinical findings. Eur Spine J. 1993;2(4):197-202. 
47. Dai L, Ni B, Yuan W, Jia L. Radiculopathy after laminectomy for cervical compression 
myelopathy. Journal of Bone and Joint Surgery - Series B. 1998;80(5):846-849. 
48. Saunders RL, Bernini PM, Shirreffs TG, Jr., Reeves AG. Central corpectomy for cervical 
spondylotic myelopathy: a consecutive series with long-term follow-up evaluation. J 
Neurosurg. 1991;74(2):163-170. 
49. Hirai T, Okawa A, Arai Y, et al. Middle-term results of a prospective comparative study of 
anterior decompression with fusion and posterior decompression with laminoplasty for the 
treatment of cervical spondylotic myelopathy. Spine. 2011;36(23):1940-1947. 
50. Chen Y, Chen D, Wang X, et al. Anterior corpectomy and fusion for severe ossification of 
posterior longitudinal ligament in the cervical spine. Int Orthop. 2009;33(2):477-482. 
51. Chiba K, Kato Y, Tsuzuki N, et al. Computer-assisted measurement of the size of ossification 
in patients with ossification of the posterior longitudinal ligament in the cervical spine. J 
Orthop Sci. 2005;10(5):451-456. 
52. Yonenobu K, Abumi K, Nagata K, Taketomi E, Ueyama K. Interobserver and intraobserver 
reliability of the Japanese Orthopaedic Association scoring system for evaluation of cervical 
compression myelopathy. Spine. 2001;26(17):1890-1895. 
Copyright © 2019 Wolters Kluwer Health, Inc. Unauthorized reproduction of this article is prohibited.
53. Tetreault L, Ibrahim A, Cote P, Singh A, Fehlings MG. A systematic review of clinical and 
surgical predictors of complications following surgery for degenerative cervical myelopathy. 
J Neurosurg Spine. 2016;24(1):77-99. 
54. Karadimas SK, Laliberte AM, Tetreault L, et al. Riluzole blocks perioperative ischemia-
reperfusion injury and enhances postdecompression outcomes in cervical spondylotic 
myelopathy. Sci Transl Med. 2015;7(316):316ra194. 
Copyright © 2019 Wolters Kluwer Health, Inc. Unauthorized reproduction of this article is prohibited.










C5 palsy was defined as a decrease in 
strength of the deltoid or biceps muscle     
C5 palsy was defined as a decrease in 
strength of the deltoid or biceps muscle as 
measured by the MMT 
    
C5 palsy was defined as a decrease in 
strength of the deltoid or biceps muscle by 
>1 point on the MMT 
    
C5 palsy was defined as a decrease in 
strength in the deltoid or biceps muscle by 
>1 point on the MMT at 24 hours after 
surgery (compared to presurgical status) 
    
MMT: manual muscle testing 
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Table 2. A Summary of Definitions used for Neurological Complications and Progression of Ossification 
































A decrease in JOA 
score or an increase 
















13 1 7.7% 
A decrease in JOA 















52 16† 30.8%† 
A decrease in JOA 

























477 1 0.2% 
An increase in 
















A decline in JOA 
score by >3 points 
during the 4 year 
follow-up, compared 











30 3 10% 
A decline in JOA 












80 24 30.0% 
A decrease in JOA 












66 3 4.5% 
A decrease in the 
JOA score by >2 
















52 13 25.0% 
A decrease in upper-
extremity and trunk 
JOA scores by >1 
point at final follow-
up compared to the 
highest score 











57 19 33.3% 
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A decrease in upper-
extremity and trunk 


















Signs and symptoms 
due to cervical 
myelopathy 














ossified lesion >50% 
of one vertebral 
body axially, or >2 
mm in thickness at 
follow-up, compared 
with measurements 
taken just after the 










30 2 6.7% 
Ossification of 
>50% of one 
vertebral body 
axially or >2mm in 
thickness at 4-year 













15 0 0.0% 
Computer assisted 
measurements of the 
size of the ossified 
lesions (described by 











53 35 66.0% 

















45 33 73.3% 
≥2mm increase in 
longitudinal extent 
and/or sagittal 

















Progression of an 
ossified lesion >2 




















72 46 63.9% 
Sagittal growth of an 
ossified mass >2mm 
or longitudinal 

































30 26 86.7% 
Increase in thickness 
>1 mm on 
30 15 50.0% 
Copyright © 2019 Wolters Kluwer Health, Inc. Unauthorized reproduction of this article is prohibited.
radiographs  
≥2 mm increase in 
existing lesions, a 
new ossified lesion 
measuring ≥2 mm, 
and bridging 
between separate 












52 27 51.9% 
C5 palsy Reduction of MMT 











544 18 3.3% 
Deterioration of 
muscle strength of 
the deltoid and the 
biceps brachii by ≥1 
grade on MMT after 
surgery, without any 




















459 32 7.0% 
Deltoid muscle 
weakness (grade ≤3 
on MMT) without 












282 11 3.9% 
Ohashi 
(2014) 





236 10 4.2% 
Deltoid muscle 
weakness (grade <3 










141 9 6.4% 
Deterioration in 
muscle power of the 
deltoid or biceps 
brachii muscle by ≥1 
grade on MMT 
without aggravation 












104 6 5.8% 
Deterioration of the 
deltoid muscle by ≥1 
grade on MMT (5 




sensory deficits or 










91 21 23.1% 
Postoperative 
symptoms of paresis 
of the deltoid/biceps 
brachii muscles 
and/or pain/sensory 










98 12 12.2% 
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Paresis of deltoid 
(MMT score 1 or 2), 
with or without 
involvement of the 
biceps, but no loss of 






























1858 43 2.3% 
Postoperative 
deterioration of 
muscle strength in 
the deltoid muscle 
by ≥1 grade on the 
MMT, with or 
without involvement 
of the biceps muscle, 
but no loss of 














54 8 14.8% 
New decline in 
deltoid muscle 
power (evaluated by 












111 3 2.7% 
New deterioration of 
muscle strength of 
the deltoid muscle 
and/or the biceps 







19 1 5.3% 
A decrease in upper 
limb muscle strength 























104 3 2.9% 
Loss of motor 
strength in the 
deltoid and/or biceps 
brachii muscles, 
sensory deficit or 
increased pain in the 









38 3 7.9% 
A decrease in 
strength of deltoid 
and biceps muscles 












138 2 1.4% 
C5 dermatome 
hypoesthesia, 
diminished or absent 











477 4 0.8% 
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postoperative deltoid 





A mild degree of 
paralysis was 
defined as a MMT 
score of 5-4; 
moderate as 3-2; and 
severe as 1-0. Motor 
dominant: muscle 
weakness with little 
or no sensory loss. 
Sensory-dominant: 
sensory loss and/or 
intractable pain with 













287 37 12.9% 
A mild degree of 
paralysis was 
defined as a MMT 
score of 5-4; 
moderate as 3-2; and 








after pain was 
relieved by a root 













188 20 10.6% 
Upper limb palsy: A 
postoperative 
decrease in upper-
limb muscle strength 
of ≥1 grade on 












159 8 5.0% 
Upper limb palsy: 
Deterioration of 
motor function by ≥1 
grade on MMT 
without aggravation 
of lower extremity 
function, the 
appearance of a new 
sensory disturbance 
between 
postoperative day 0 
and 2 months after 













424 22 5.2% 
Posterio
r 
433 27 6.2% 
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deterioration of 
motor function and 




signs and symptoms 
of other cervical 









477 3 0.6% 
Upper limb palsy: 
Weakness of key 
muscles in the upper 






















The strength of the 





elbow flexion, and 
elbow extension, 
respectively, using a 
calibrated hand-held 
dynamometer before 
and 2 weeks after 
surgery. Grip 
strength was 
assessed using a grip 
dynamometer. 
Decreased arm 
strength was defined 
as decreased strength 
in ≥1 muscle as 
evaluated by either 
the hand-held or grip 
dynamometer (cut-
off points based on 
postoperative/preope














defined as a change 
of at least two grades 





smaller grade change 
or regression of 
improvement was 

















A cord flattening 












138  NR NR 












19  NR NR 
Residual anterior 
compression of 
spinal cord: (1) 
Effacement of 
anterior CSF buffer 
on T2 sagittal and 
axial images; (2) 
Evidence of anterior 
compression of cord 
substance on T1 















P = Prospective, R = Retrospective 
#Time of diagnosis or onset or period of evaluation (H = hour(s); D = day(s); W = week(s); M = month(s); Y = 
year(s); (…) = mean follow up) 
^Extrapolated from Table 5 in Kato et al (1998) 
†Three patients were categorized as “early deterioration” while ten patients were classified as “late 
deterioration” 
^^Extrapolated from Table 3 in Ikenaga et al (2005) 
††Number of arms assessed and number of arms with decreased strength  
*Incidence of OPLL progression based on a sagittal growth >2mm 
**Incidence of OPLL progression based on a longitudinal growth over one vertebral body 
%Six patients exhibited residual anterior compression of the spinal cord immediately after surgery. At 2, years, 
16 patients displayed residual anterior compression, including the six patient who had immediate evidence of 
inadequate decompression (of the new 10, seven had progression of kyphotic changes and 3 had 
spondylolisthesis)  
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Mean Incidence at 





5/5 2.3% (0.2%-30.8%) 679
Late-onset 
deterioration 





Progression of ossified 
lesions 
10/10 56.5% (0.0%-86.7%) 428
C5 palsy 16/20 3.5% (0.6%-23.1%) 6078
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